When the endometrioid adenocarcinoma and the endometrial stromal sarcoma meet: A report of an extremely rare case.
Endometrial stromal sarcoma
Endometrioid adenocarcinoma
Neoplasia
Undifferentiated stromal sarcoma
Uterus
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
18
03
2022
revised:
15
05
2022
accepted:
17
05
2022
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
3
6
2022
Statut:
epublish
Résumé
Collision tumors are characterized by the coexistence of two adjacent, but histologically distinct tumors. This entity can occur between tumors originating from the same organ or between metastases from other sites. A 49-year-old postmenopausal female with abnormal vaginal bleeding and abdominal pain was diagnosed with two coexistent tumors, a grade 1 endometrioid carcinoma and a pT2 undifferentiated stromal sarcoma (USS). On the first time, the patient underwent a total abdominal hysterectomy with bilateral salpingo-oopherectomy and one month later, she was diagnosed with recurrence. Then, a second surgical excision of the recurrent tumor was performed including exploratory laparotomy and anterior pelvic exenteration. She had an uneventful postoperative period, but unfortunately a month following the second operation she passed away. We aim to raise awareness of these rare synchronous malignancies and highlight the importance of having a broad differential diagnosis in a patient presenting with abnormal vaginal bleeding. Further studies with larger patient populations are needed to shed light in etiology and pathogenesis of the concurrence of two malignancies with different embryological origin in the same organ, in order to optimize management of these patients.
Identifiants
pubmed: 35652060
doi: 10.1016/j.gore.2022.101004
pii: S2352-5789(22)00084-4
pmc: PMC9149188
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101004Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Int J Gynecol Cancer. 2016 Jan;26(1):2-30
pubmed: 26645990
Anticancer Res. 2009 May;29(5):1495-7
pubmed: 19443356
Prz Menopauzalny. 2017 Mar;16(1):23-25
pubmed: 28546804
J Clin Pathol. 2015 May;68(5):325-32
pubmed: 25595274
Int J Clin Exp Pathol. 2015 May 01;8(5):5242-6
pubmed: 26191224
Obstet Gynecol Int. 2011;2011:470795
pubmed: 22007228
Oncotarget. 2020 Dec 29;11(52):4813-4821
pubmed: 33447349
Int J Surg Oncol. 2021 Sep 01;2021:2626635
pubmed: 34518784
Arch Pathol Lab Med. 2018 Apr;142(4):536-541
pubmed: 29293021
Gynecol Oncol Rep. 2015 May 01;13:8-12
pubmed: 26425710
Am J Surg Pathol. 2019 May;43(5):662-669
pubmed: 30789359
Int J Gynecol Pathol. 2020 Jul;39(4):373-378
pubmed: 31157684
Adv Anat Pathol. 2014 Nov;21(6):383-93
pubmed: 25299308